Clinical Trials Directory

Trials / Unknown

UnknownNCT00033059

Assessment of Potential Interactions Between Cocaine and Tolcapone - 1

Assessment of Potential Interactions Between Intravenous Cocaine and Tolcapone

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
16 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the potential interactions between intravenous (IV) cocaine and tolcapone.

Detailed description

Double-blind, inpatient study by screening responses to cocaine infusions of 20 and 40 mg i.v. subjects into 1 of 2 treatment groups to assess potential interactions between i.v. cocaine infusion and treatment with tolcapone.

Conditions

Interventions

TypeNameDescription
DRUGTolcapone

Timeline

Start date
2001-07-01
Completion
2002-03-01
First posted
2002-04-08
Last updated
2017-01-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00033059. Inclusion in this directory is not an endorsement.